HomeCompareVMLUX vs JNJ

VMLUX vs JNJ: Dividend Comparison 2026

VMLUX yields 2.88% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VMLUX wins by $4.0K in total portfolio value
10 years
VMLUX
VMLUX
● Live price
2.88%
Share price
$10.93
Annual div
$0.32
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.0K
Annual income
$347.14
Full VMLUX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — VMLUX vs JNJ

📍 VMLUX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVMLUXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VMLUX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VMLUX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VMLUX
Annual income on $10K today (after 15% tax)
$245.03/yr
After 10yr DRIP, annual income (after tax)
$295.07/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $408.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VMLUX + JNJ for your $10,000?

VMLUX: 50%JNJ: 50%
100% JNJ50/50100% VMLUX
Portfolio after 10yr
$22.0K
Annual income
$587.46/yr
Blended yield
2.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VMLUX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VMLUX buys
0
JNJ buys
0
No recent congressional trades found for VMLUX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVMLUXJNJ
Forward yield2.88%3.36%
Annual dividend / share$0.32$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$24.0K$20.0K
Annual income after 10y$347.14$827.78
Total dividends collected$3.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VMLUX vs JNJ ($10,000, DRIP)

YearVMLUX PortfolioVMLUX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,988$288.27$10,676$355.77+$312.00VMLUX
2$12,053$296.04$11,407$389.39+$646.00VMLUX
3$13,201$303.49$12,198$426.53+$1.0KVMLUX
4$14,435$310.63$13,056$467.62+$1.4KVMLUX
5$15,763$317.46$13,987$513.12+$1.8KVMLUX
6$17,191$323.99$14,998$563.56+$2.2KVMLUX
7$18,724$330.21$16,098$619.52+$2.6KVMLUX
8$20,371$336.14$17,295$681.69+$3.1KVMLUX
9$22,139$341.78$18,599$750.82+$3.5KVMLUX
10$24,036$347.14$20,022$827.78+$4.0KVMLUX

VMLUX vs JNJ: Complete Analysis 2026

VMLUXStock

This low-cost municipal bond fund seeks to provide income exempt from federal taxes and typically appeals to investors in higher tax brackets. The fund holds high-quality short-term municipal bonds with an average duration of approximately 2 years, a bit longer than the Short-Term Tax-Exempt Fund. Risks of the fund include the fact that changes in interest rates, both up and down, can affect the fund by resulting in lower bond prices or an eventual decrease in income for the fund. Investors who are looking for a modest level of federal tax-exempt interest income and can tolerate some income and share price risk may wish to consider this fund.

Full VMLUX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this VMLUX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VMLUX vs SCHDVMLUX vs JEPIVMLUX vs OVMLUX vs KOVMLUX vs MAINVMLUX vs ABBVVMLUX vs MRKVMLUX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.